Lotus Pharmaceuticals, Inc.
LTUS
$0.0053
-$0.0007-11.67%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | 1.25M | 1.77M | 2.24M | -3.53M | 6.70M |
| Total Depreciation and Amortization | 410.30K | 410.90K | 407.80K | 910.40K | 447.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | -92.20K | 0.00 | 2.10M | 7.59M | 123.80K |
| Change in Net Operating Assets | 2.35M | 907.30K | -1.18M | 2.82M | 2.80M |
| Cash from Operations | 3.92M | 3.09M | 3.56M | 7.80M | 10.07M |
| Capital Expenditure | -4.65M | -3.53M | -3.60M | -7.39M | -10.27M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -4.65M | -3.53M | -3.60M | -7.39M | -10.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 300.00 | 16.10K | 8.40K | 39.40K | 22.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -727.50K | -424.50K | -29.00K | 442.30K | -181.10K |